Swedish Orphan Biovitrum AB (publ)
F:B6E
Swedish Orphan Biovitrum AB (publ)
F:B6E
Precio:
40,74
EUR
-1,26%
Capitalización de mercado:
€13,85 B
Agregar nota
Añadir objetivo
Captura tus ideas y establece un objetivo
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
Basado en
Margen de seguridad
0%
10%
20%
30%
40%
50%
Tu precio objetivo
Vinculado a
precio actual
· En zona de compra
Cargando
Nota vinculada
Elige la acción que deseas seguir con un precio objetivo
Vistos recientemente
|
S
|
Swedish Orphan Biovitrum AB (publ)
F:B6E
|
SE |
|
U
|
Unicaja Banco SA
SWB:7UB
|
ES |
|
Pc Partner Group Ltd
SGX:PCT
|
HK |
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
O
|
Orion Oyj
F:OFK
|
FI |
|
Compania de Minas Buenaventura SAA
F:MBU
|
PE |
|
Star Entertainment Group Ltd
ASX:SGR
|
AU |
|
M
|
Mitsubishi Heavy Industries Ltd
XBER:MIH
|
JP |
|
Ecovyst Inc
NYSE:ECVT
|
US |
|
N
|
Naturgy Energy Group SA
DUS:GAN
|
ES |
|
A
|
Amada Co Ltd
XMUN:AA2
|
JP |
Reverse DCF
Market Expectations:
Unrealistic
To justify the current price, Netflix Inc. must grow revenue by 36% annually over the next 5 years, which is outside the range of what's considered realistic.
| Revenue Growth Rate | DCF Value | |
|---|---|---|
|
Realistic Range
|
Realistic Low: 10%
|
$601.26
Overvalued by 45%
|
|
Historical: 21%
|
$758.26
Overvalued by 36%
|
|
|
Current DCF: 23%
|
$789.44
Overvalued by 32%
|
|
|
Wall Street: 24%
|
$831.32
Overvalued by 28%
|
|
|
Realistic High: 30%
|
$900.12
Overvalued by 12%
|
|
|
Implied by Price: 36%
|
$977.59
Matches Stock Price
|
Below current price
Above current price
